Ryzodeg 70/30 and Repatha drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ryzodeg 70/30 (insulin aspart; insulin degludec) and Repatha (evolocumab). Common drug interactions include cardio-respiratory arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Ryzodeg 70/30 and Repatha. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ryzodeg 70/30?

Ryzodeg 70/30 has active ingredients of insulin aspart; insulin degludec. eHealthMe is studying from 713 Ryzodeg 70/30 users. Check the latest studies of Ryzodeg 70/30.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,256 Repatha users. Check the latest studies of Repatha.

On Jul, 12, 2026

21 people who take Ryzodeg 70/30 and Repatha together, and have interactions are studied.

Ryzodeg 70/30 and Repatha drug interactions.

What are the common drug interactions of Ryzodeg 70/30 and Repatha, by gender? *:

female:

n/a

male:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
Hyperkinetic heart syndrome (hyperkinetic heart disease is when the heart is beating faster that it should be)
Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
Hypokinesia (decreased bodily movement)
Akinesia (loss of control of voluntary muscle movements)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)

What are the common drug interactions of Ryzodeg 70/30 and Repatha, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
Hyperkinetic heart syndrome (hyperkinetic heart disease is when the heart is beating faster that it should be)
Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)
Hypokinesia (decreased bodily movement)
Akinesia (loss of control of voluntary muscle movements)
Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)

60+:

n/a

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 21 people, 100.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 15 people, 71.43%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 9.52%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Diabetes: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ryzodeg 70/30 and Repatha?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously